JOHNSON & JOHNSON — Director's Dealing 2020

Jan 6, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2019-12-27

Reporting Person: Decker Robert J (Controller, CAO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	12447.0000	Direct
Common Stock	524.0000	Indirect
Common Stock	134.0000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Options (Right to Buy)	$72.5400	2023-01-13	Common Stock (18462.0000)		Direct
Employee Stock Options (Right to Buy)	$90.4400	2024-02-09	Common Stock (16928.0000)		Direct
Employee Stock Options (Right to Buy)	$100.0600	2025-02-09	Common Stock (5635.0000)		Direct
Employee Stock Options (Right to Buy)	$101.8700	2026-02-08	Common Stock (6999.0000)		Direct
Employee Stock Options (Right to Buy)	$115.6700	2027-02-13	Common Stock (4075.0000)		Direct
Employee Stock Options (Right to Buy)	$129.5100	2028-02-11	Common Stock (3107.0000)		Direct
Employee Stock Options (Right to Buy)	$131.9400	2029-02-11	Common Stock (4212.0000)		Direct
Restricted Share Units	$		Common Stock (866.0000)		Direct
Restricted Share Units	$		Common Stock (655.0000)		Direct
Restricted Share Units	$		Common Stock (720.0000)		Direct

Footnotes

F1: Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (12/31/2019).

F2: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (12/31/2019).

F3: Vested and exercisable on the third anniversary of the date of the grant.

F4: Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant.